Global science innovation is rapidly shifting to Asia as investment, talent, and R&D infrastructure surge, challenging Western dominance and reshaping pharmaceutical competition worldwide.
China is intensifying efforts to attract top scientific talent, a move inadvertently boosted by recent U.S. policies under Trump. Restrictions on Chinese researchers have prompted many to consider opportunities in …